Compugen (CGEN) director discloses initial share and option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Compugen Ltd director Sanford S. Zweifach reported his initial holdings, including 12,680 Ordinary Shares, which include 9,216 restricted stock units that vest over time, subject to continued service. He also holds several share options to buy Ordinary Shares at exercise prices between $1.15 and $14.40, with expirations from 2029 through 2035.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
ZWEIFACH SANFORD S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Option (right to buy) — 10,000 shares (Direct);
Ordinary Shares — 12,680 shares (Direct)
Footnotes (1)
- Includes 9,216 restricted stock units ("RSUs"). 1,716 RSUs vest in 11 equal quarterly installments commencing on April 1, 2026; and 7,500 RSUs vest 25% on October 1, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Fully vested. This option vested 25% on April 1, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vested 25% on October 1, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vested 25% on October 1, 2025 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vests 25% on October 1, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
FAQ
What does the Form 3 filing by Compugen (CGEN) director Sanford S. Zweifach show?
The Form 3 shows Sanford S. Zweifach’s initial beneficial ownership in Compugen. It reports his Ordinary Share holdings and multiple share option positions, providing a baseline of his equity exposure as a company director going forward.
What restricted stock units (RSUs) are disclosed for Compugen (CGEN) director Sanford S. Zweifach?
The filing states his Ordinary Shares include 9,216 RSUs. Of these, 1,716 RSUs vest in 11 equal quarterly installments from April 1, 2026, and 7,500 RSUs vest from October 1, 2026 on a quarterly schedule, contingent on continued service.
Are Sanford S. Zweifach’s Compugen (CGEN) options already vested?
Some options are described as fully vested, while others vest over time. Footnotes explain that different grants vest 25% on specific dates and the remainder in 12 equal quarterly installments, all subject to his continued service.
Does the Compugen (CGEN) Form 3 show any insider buying or selling by Sanford S. Zweifach?
The Form 3 primarily records holdings, not recent trades. Transaction fields are categorized as holdings with unknown transaction codes, indicating the filing sets an ownership baseline rather than reporting new purchases or sales.